Today we’re announcing our Series B.
We’ve raised $200M at a $2B valuation from Greenoaks with participation from Index Ventures, Hanabi, A*, Bain Capital Ventures, CVS Health Ventures, and Definition.
Our mission is to simulate all eight billion people on earth, accurately.